SREBF1 and cancer: Collectively, these disruptions create an imbalance between lipogenesis (SREBP-1c, PPARγ) and energy homeostasis (AMPK), fostering a pro-inflammatory, obesogenic environment that increases oxidative stress, accelerates HFD-induced cellular damage, and heightens the risk of cancer and metabolic disease progression.